From the composition recognized
Pharmacological Group
There is no detailed description.
Used in the treatment
- N76.8 Other specified inflammation of vagina and vulva
- N76 Other inflammation of vagina and vulva
- K63.8.0* Dysbiosis
- K59.1 Functional diarrhoea
- A60 Anogenital herpesviral [herpes simplex] infection
- A56.2 Chlamydial infection of genitourinary tract, unspecified
- A54 Gonococcal infection
- A09 Other gastroenteritis and colitis of infectious and unspecified origin
- Z51.4 Preparatory care for subsequent treatment, not elsewhere classified
- P78.8 Other specified perinatal digestive system disorders
- N89.8 Other specified noninflammatory disorders of vagina
- Y40 Adverse effects in therapeutic use, systemic antibiotics
- Z34 Supervision of normal pregnancy
- Z35.3 Supervision of pregnancy with history of insufficient antenatal care
- N89.9 Noninflammatory disorder of vagina, unspecified